Results 131 to 140 of about 93,237 (289)
Phenolic Profile and Bioactive Prospects of Wild Annona Species From Angola
ABSTRACT Annona species (Annonaceae family) are valued for their nutritional and medicinal importance, especially in traditional medicine. This study investigated the phenolic profiles of the Angolan Annona muricata, Annona squamosa, and Annona senegalensis leaves, stem barks, and seeds hydroethanolic, infusion, and decoction extracts, also evaluating ...
Josefa Rangel +9 more
wiley +1 more source
Hypofuran B, drynaran, and a series of analogs are obtined by crossed aldol condensation from furfural dereivatives. Compunds are tested for in vitro activity agaisnt Trypanosoma cruzi and Plasmodium falciparum. Best results are obtained Against P. falciparum, with IC50 values ranging from 5,35 to 10,35 µg mL−1.
Cristiane Aparecida Franco +11 more
wiley +1 more source
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
Andrea Cortegiani +4 more
openalex +2 more sources
A Case of Chloroquine-Induced Cardiomyopathy That Presented as Sick Sinus Syndrome [PDF]
Jae Hak Lee +13 more
openalex +1 more source
Investigation of the structure‐activity relationship on W482 (1) with a pyrimidine‐2,4‐diamine scaffold culminated in analog 51 with enhanced anti‐plasmodial activity. Forward genetics and phenotypic examination revealed the ABCI3 transporter protein as a putative resistance mechanism.
Mahta Mansouri +14 more
wiley +1 more source
Chemotherapy of Glomerulonephritis, Particulary on the Treatment with Chloroquine
S. Tsuji +13 more
openalex +2 more sources
Chloroquine or hydroxychloroquine for prophylaxis of COVID-19 [PDF]
Nicola Principi, Susanna Esposito
openalex +1 more source
Searching for Novel Antiviral Agents as COVID19 Treatments: Guanidino Diaryl Thioureas
Structure of the "hit‐compound" found and the proposed interaction with the active site of the TMPRSS2 protease, involving a reversible mechanism of action, are shown. The COVID‐19 pandemic highlighted the urgent need for effective antiviral treatments targeting SARS‐CoV‐2.
Marco Minneci +6 more
wiley +1 more source

